Ann Costello
Fortuna: 45 642 $ al 31/07/2026
Fortuna: 45 642 $ al 31/07/2026
Ann Costello is currently an Independent Director at Elekta AB since 2024, a Director at Ibex Medical Analytics Ltd., and an Independent Director at Freenome, Inc. starting in 2026.
Formerly, Ms. Costello was Head of Diagnostics Solutions Business at Roche Group from 2020 to 2023.
Education includes an undergraduate degree from Technological University Dublin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/04/2026 | 9.000 ( 0 % ) | 45 642 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ELEKTA AB | Director/Miembro de la Junta | 01/09/2024 |
Ibex Medical Analytics Ltd.
Ibex Medical Analytics Ltd. Packaged SoftwareTechnology Services Develops and operates medical analysis platform for pathology and cancer diagnostics | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | 02/01/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Elekta AB
Elekta AB Medical SpecialtiesHealth Technology Manufactures radiation oncology and neurosurgery instruments | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
Ibex Medical Analytics Ltd.
Ibex Medical Analytics Ltd. Packaged SoftwareTechnology Services Develops and operates medical analysis platform for pathology and cancer diagnostics | Technology Services |
Technological University Dublin
Technological University Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.